<DOC>
	<DOCNO>NCT02253862</DOCNO>
	<brief_summary>Study assess effect single-dose steady-state tipranavir/ritonavir 500 mg/200 mg single-dose pharmacokinetics tadalafil 10 mg</brief_summary>
	<brief_title>Pharmacokinetic Tadalafil Co-administered With Tipranavir/Ritonavir Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Tipranavir</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>1 . Signed informed consent 2 . Healthy male subject age 18 year 55 year inclusive 3 . Weighing least 40 kg 4 . Volunteers must hospitalize day pharmacokinetic assessment regimen 5 . Volunteers must willing complete studyrelated activity 6 . Each volunteer must valid social security regimen 7 . Each volunteer must acceptable medical history , physical examination laboratory test 8 . Volunteers negative HIV serology 1 . History presence allergy study drug component drug class , history drug allergy , opinion physician responsible , contraindicate participation . ( If heparin use pharmacokinetic ( PK ) sampling , subject history sensibility heparin heparininduced thrombocytopenia enrol ) 2 . Any finding medical examination ( include blood pressure , pulse rate , electrocardiogram ) deviate normal clinical relevance 3 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunologic , haematological , oncological hormonal disorder 4 . Known elevate liver enzyme past clinical trial compound ( experimental market ) 5 . Clinically relevant laboratory abnormality abnormal laboratory value &gt; Grade 1 , base Division AIDS Grading Scale 6 . Subjects history illness allergy , opinion investigator , might confound result study pose additional risk administer tipranavir , ritonavir tadalafil subject 7 . Volunteers use form organic nitrate , either regularly and/or intermittently ( contraindication use tadalafil ) 8 . Hypersensitivity tadalafil , tipranavir , ritonavir excipients 9 . Concurrent treatment experimental compound 10 . Inadequate venous access 11 . Contraindications tadalafil : Volunteers mild moderate hepatic impairment , Renal insufficiency Cardiovascular disease ( patient myocardial infarction within last 90 day , unstable angina angina occur sexual intercourse , patient New York Heart Association Class 2 great heart failure last 6 month , patient uncontrolled arrhythmias , hypotension ( &lt; 90/50 mm Hg ) , uncontrolled hypertension ( &gt; 170/100 mm Hg ) , patient stroke within last 6 month ) 12 . Clinically unacceptable result screen physical examination 13 . Use investigational medication within 30 day study entry 14 . Patients hospitalize medical social establishment , reason research 15 . People deprive judicial administrative freedom .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>